BREAKING
CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 9 minutes ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 23 minutes ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 41 minutes ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 55 minutes ago Science Applications International (SAIC) Beats Q4 EPS Estimates 59 minutes ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 1 hour ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 3 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 4 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 4 hours ago MEOH Stock Plunges 10.9% to $51.75 Despite Jefferies and UBS Upgrades 4 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 9 minutes ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 23 minutes ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 41 minutes ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 55 minutes ago Science Applications International (SAIC) Beats Q4 EPS Estimates 59 minutes ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 1 hour ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 3 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 4 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 4 hours ago MEOH Stock Plunges 10.9% to $51.75 Despite Jefferies and UBS Upgrades 4 hours ago
ADVERTISEMENT
Breaking News

CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25

Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4% wider).

$CTMX
March 16, 2026 1 min read

Q4 2025 loss at CytomX Therapeutics, Inc. (CTMX) widened to $0.20 per share GAAP, worse than the -$0.09 estimate (116.4% wider).

A detailed analysis of CytomX Therapeutics, Inc.’s quarter follows shortly on AlphaStreet.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

Related: CytomX Therapeutics, Inc. (CTMX) Reports Q4 Earnings | ANRO: Alto Neuroscience (ANRO) Reports Q4 Loss of $2.19/Share, Missing Estimates by 434% | ACIU: AC Immune (ACIU) Q4 Loss Narrows to $0.14/Share vs $0.17 Estimate, Revenue Plunges 70.3% | XBIO: Xenetic Biosciences (XBIO) Reports Narrower Q4 Loss of $0.22/Share, Beating $0.52 Estimate by 57.7% | SVRA: Savara (SVRA) Reports Q4 Loss of $0.13 Per Share, Flat Year-Over-Year | Full CTMX analysis on AlphaStreet

ADVERTISEMENT
Tags: #CTMX

Related Articles